Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

Interleukin-15 augments NK cell–mediated ADCC of alemtuzumab in patients with CD52 + T-cell malignancies

Milos D. Miljkovic, Sigrid P. Dubois, Jürgen R. Müller, Bonita Bryant, Elaine Ma, Kevin C. Conlon, Thomas A. Waldmann

Blood Adv (2023) 7 (3): 384–394.

https://doi.org/10.1182/bloodadvances.2021006440

Published: 2023

Includes: Supplemental data

Journal Articles

Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma

Anusara Daenthanasanmak, Richard N. Bamford, Makoto Yoshioka, Shyh-Ming Yang, Philip Homan, Baktiar Karim, Bonita R. Bryant, Michael N. Petrus, Craig J. Thomas, Patrick L. Green, Milos D. Miljkovic, Kevin C. Conlon, Thomas A. Waldmann

Blood Adv (2022) 6 (7): 2346–2360.

https://doi.org/10.1182/bloodadvances.2021005948

Published: 2022

Includes: Supplemental data

Journal Articles

Next-generation sequencing–based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCL

Milos D. Miljkovic, Christopher Melani, Stefania Pittaluga, Rahul Lakhotia, Nicole Lucas, Allison Jacob, Erik Yusko, Elaine S. Jaffe, Wyndham H. Wilson, Mark Roschewski

Blood Adv (2021) 5 (20): 4198–4210.

https://doi.org/10.1182/bloodadvances.2020003679

Published: 2021

Includes: Supplemental data